Global Gastrointestinal (GI) Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent, and Esophageal Stent.By Application;
Biliary Disease, Colorectal Cancer, Stomach Cancer, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Gastrointestinal (GI) Stents Market (USD Million), 2021 - 2031
In the year 2023, the Global Gastrointestinal (GI) Stents Market was valued at USD 1,787.04 million. The size of this market is expected to increase to USD 2,267.47 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 3.5%.
The global gastrointestinal (GI) stents market stands as a critical component of medical care, offering minimally invasive solutions for patients suffering from gastrointestinal disorders. GI stents, comprising self-expandable metal stents (SEMS) and plastic stents, play a pivotal role in the management of various conditions such as colorectal cancer, esophageal cancer, gastroduodenal obstruction, and benign strictures. These devices are designed to alleviate symptoms, restore luminal patency, and provide palliative care, thereby improving the quality of life for patients facing debilitating gastrointestinal ailments.
As the prevalence of gastrointestinal diseases continues to rise worldwide due to factors such as aging populations, changing dietary habits, and increasing incidence of risk factors such as obesity and smoking, the demand for GI stents is witnessing a steady ascent. Moreover, advancements in stent design, materials, and delivery systems, coupled with the growing adoption of endoscopic procedures and minimally invasive techniques, are further propelling market growth. Challenges such as complications associated with stent placement, stringent regulatory requirements, and pricing pressures pose significant hurdles for market players. Nonetheless, with ongoing research and development efforts aimed at enhancing stent efficacy, safety, and biocompatibility, the global GI stents market is poised for continued expansion and innovation in the years ahead.
Global Gastrointestinal (GI) Stents Market Recent Developments
-
In December 2020, Boston Scientific announced the launch of its WallFlex Biliary RX Fully Covered Stent with Controlled Release Technology in the United States. The stent is designed to provide controlled release of a drug to help prevent tissue overgrowth.
-
In November 2020, Cook Medical received FDA clearance for its Evolution® Controlled-Release Esophageal Stent. The stent features a dual-layer design that aims to reduce the risk of tissue overgrowth and migration
Segment Analysis
The segmentation by Product includes Self-Expanding Metal Stents (SEMS), Self-Expanding Plastic Stents (SEPS), and Covered Stents, among others. Each type of stent offers unique benefits and is used for specific applications within the gastrointestinal tract. Self-expanding metal stents, for example, are widely used due to their flexibility and ability to maintain luminal patency in strictures caused by conditions such as colorectal cancer or esophageal strictures. On the other hand, covered stents are preferred in cases where there is a risk of tissue ingrowth or migration.
The segmentation by Application covers various gastrointestinal disorders and conditions where stents are employed for therapeutic purposes. These include esophageal cancer, colorectal cancer, biliary diseases, and gastric outlet obstruction, among others. The increasing incidence of gastrointestinal cancers, along with the growing adoption of minimally invasive procedures, is driving the demand for GI stents across different applications.
Global Gastrointestinal (GI) Stents Segment Analysis
In this report, the Global Gastrointestinal (GI) Stents Market has been segmented by Product, Application, and Geography.
Global Gastrointestinal (GI) Stents Market, Segmentation by Product
The Global Gastrointestinal (GI) Stents Market has been segmented by Product into Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent and Esophageal Stent.
Biliary stents are designed to relieve obstructions in the bile duct caused by conditions such as gallstones, tumors, or strictures. They facilitate bile drainage and maintain patency in the biliary system, thereby alleviating symptoms and preventing complications such as jaundice or cholangitis. Duodenal stents are deployed in the duodenum to palliate malignant obstructions or strictures, allowing for the passage of food and fluids and improving quality of life for patients with advanced pancreatic or periampullary cancers.
Colonic stents are utilized in the management of colorectal obstructions, which may result from malignant tumors, benign strictures, or complications of inflammatory bowel disease. These stents provide temporary relief by restoring luminal patency and enabling bowel decompression, often serving as a bridge to surgery or as a palliative measure in patients with advanced disease. Pancreatic stents are employed in the treatment of pancreatic duct strictures or leaks, commonly associated with chronic pancreatitis or postoperative complications, to promote ductal drainage and prevent pancreatic fluid collections.
Esophageal stents are deployed in the esophagus to relieve dysphagia or dysphagia-related symptoms secondary to malignant or benign strictures, esophageal perforations, or fistulas. These stents restore luminal patency, allowing for the passage of food and liquids, and may be used as a palliative measure in patients with advanced esophageal cancer or as a bridge to definitive treatment modalities such as surgery or radiation therapy.
The adoption of GI stents is driven by several factors, including the growing prevalence of gastrointestinal disorders such as pancreatic cancer, colorectal cancer, and biliary diseases, which necessitate effective treatment options to alleviate symptoms and improve patient outcomes. Technological advancements in stent design, materials, and delivery systems have enhanced the safety, efficacy, and applicability of GI stents, contributing to their widespread adoption in clinical practice. However, challenges such as stent migration, occlusion, or tissue ingrowth remain significant concerns that require ongoing research and development efforts to address.
Global Gastrointestinal (GI) Stents Market, Segmentation by Application
The Global Gastrointestinal (GI) Stents Market has been segmented by Application into Biliary Disease, Colorectal Cancer, Stomach Cancer and Others.
One of the primary applications of GI stents is in the treatment of Biliary Disease, which encompasses conditions affecting the bile ducts and gallbladder. Biliary stents are commonly used to relieve obstructions caused by conditions such as gallstones, strictures, or tumors. By providing a conduit for bile flow, these stents help alleviate symptoms such as jaundice, pain, and infection, improving patient quality of life and supporting overall liver function.
Colorectal Cancer represents another significant application area for GI stents. Colorectal stents are employed in the palliative treatment of malignant strictures or obstructions within the colon or rectum. By deploying a stent, physicians can restore luminal patency, allowing for the passage of stool and reducing symptoms such as bowel obstruction, abdominal pain, and constipation. In some cases, colorectal stents serve as a bridge to surgery, facilitating preoperative decompression and optimizing patient condition prior to definitive treatment.
Stomach Cancer, characterized by the abnormal growth of malignant cells within the stomach lining, presents another opportunity for GI stent intervention. Stomach stents may be deployed to alleviate symptoms associated with gastric outlet obstruction, a common complication of advanced gastric tumors. By maintaining luminal patency and enabling oral intake, gastric stents help improve nutritional status, alleviate nausea and vomiting, and enhance overall patient comfort.
Beyond these primary applications, GI stents find utility in addressing a spectrum of other gastrointestinal conditions. This may include benign strictures, fistulas, perforations, or leaks arising from various etiologies such as inflammatory bowel disease, diverticular disease, or iatrogenic injury. In these cases, stents serve diverse therapeutic purposes, including luminal dilation, diversion of gastrointestinal contents, or reinforcement of tissue integrity, depending on the specific clinical scenario.
Global Gastrointestinal (GI) Stents Market, Segmentation by Geography
In this report, the Global Gastrointestinal (GI) Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Gastrointestinal (GI) Stents Market Share (%), by Geographical Region, 2024
North America holds a prominent position in the GI stents market, driven by factors such as the high prevalence of gastrointestinal disorders, advanced healthcare infrastructure, and the presence of key market players. Rising cases of diseases such as colorectal cancer and esophageal cancer contribute to the demand for GI stents in the region. Additionally, favorable reimbursement policies and increasing adoption of minimally invasive procedures further propel market growth.
In Europe, the GI stents market is fueled by factors such as the aging population, increasing incidence of gastrointestinal diseases, and advancements in medical technology. Countries like Germany, the UK, and France are witnessing significant demand for GI stents owing to the high prevalence of diseases like inflammatory bowel disease (IBD) and pancreatic cancer. Moreover, initiatives aimed at improving access to healthcare services and promoting early disease detection drive market expansion in the region.
The Asia Pacific region presents lucrative opportunities for GI stent manufacturers due to factors such as the large population base, rising healthcare expenditure, and improving healthcare infrastructure. Countries like China, India, and Japan are witnessing increasing cases of gastrointestinal disorders, driving the demand for GI stents. Moreover, growing awareness about minimally invasive procedures and the adoption of advanced medical devices contribute to market growth in the region.
In the Middle East and Africa (MEA) region, the GI stents market is influenced by factors such as improving healthcare infrastructure, rising prevalence of gastrointestinal diseases, and increasing investments in healthcare. Countries in the Middle East, such as Saudi Arabia and the UAE, are witnessing a surge in demand for GI stents due to the high incidence of diseases like gastric cancer and gastrointestinal bleeding. Moreover, initiatives aimed at enhancing healthcare access and promoting medical tourism further support market growth.
Latin America also presents opportunities for GI stent manufacturers, driven by factors such as the growing geriatric population, increasing prevalence of gastrointestinal disorders, and improving healthcare facilities. Countries like Brazil and Mexico are experiencing rising demand for GI stents due to the high burden of diseases like colorectal cancer and peptic ulcers. Additionally, government initiatives focused on expanding healthcare infrastructure and improving patient access to medical devices contribute to market expansion in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Gastrointestinal (GI) Stents Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunitiy Analysis
Drivers:
- Prevalence of Gastrointestinal Disorders
- Advancements in Stent Technology
-
Aging Population and Increasing Endoscopic Procedures - Firstly, the aging population worldwide is a major catalyst for the growth of the GI stents market. As populations age, the prevalence of gastrointestinal disorders, such as colorectal cancer, pancreatic cancer, and gastrointestinal strictures, tends to increase. Elderly individuals are particularly susceptible to these conditions due to age-related changes in the digestive system and a higher incidence of chronic diseases. Consequently, there is a rising need for interventions to manage these conditions and improve patients' quality of life. GI stents play a crucial role in alleviating symptoms and restoring normal gastrointestinal function in elderly patients with obstructive gastrointestinal diseases. The growing geriatric population, coupled with the rising incidence of gastrointestinal disorders, is driving the demand for GI stents globally.
The increasing adoption of endoscopic procedures is fueling the demand for GI stents. Endoscopy has emerged as a preferred diagnostic and therapeutic modality for various gastrointestinal conditions due to its minimally invasive nature and high efficacy. Endoscopic procedures, such as endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS), are commonly used for the placement of GI stents to relieve obstructions, drain fluids, and treat leaks or fistulas in the gastrointestinal tract. The growing acceptance of endoscopic techniques among healthcare providers and patients is driving the demand for GI stents as an integral component of endoscopic interventions. Furthermore, technological advancements in endoscopic devices and techniques have enhanced the safety, precision, and effectiveness of GI stent placement, further propelling market growth.
Restraints:
- Availability of Alternative Treatment Modalities
- Stringent Regulatory Approval Processes
-
Complications Associated with Stenting Procedures - Complications associated with gastrointestinal (GI) stenting procedures pose a significant restraint on the global GI stents market, impacting both patients and healthcare providers. While GI stents are valuable medical devices used to alleviate symptoms and improve quality of life in patients with various gastrointestinal conditions, the occurrence of complications can lead to adverse outcomes and increase the burden on healthcare systems.
One of the primary complications associated with GI stenting procedures is stent migration. Stent migration occurs when the stent dislodges from its intended position within the gastrointestinal tract, leading to inadequate symptom relief and potential obstruction or perforation of the digestive system. Stent migration can occur immediately after placement or over time, necessitating additional interventions such as repositioning or replacement of the stent.
Another common complication is stent occlusion or blockage, which can result from tumor ingrowth, tissue hyperplasia, or food impaction within the stent lumen. Stent occlusion compromises the effectiveness of the stent in maintaining luminal patency and symptom relief, requiring endoscopic interventions such as stent cleaning, dilation, or replacement to restore functionality.
Stent-related complications such as tissue overgrowth, ulceration, and perforation can occur due to the mechanical interaction between the stent and the gastrointestinal mucosa. These complications may lead to tissue damage, bleeding, infection, or even life-threatening conditions, necessitating prompt medical attention and potential surgical interventions to mitigate risks and manage complications.
The risk of complications associated with GI stenting procedures is influenced by various factors, including patient characteristics, underlying gastrointestinal pathology, stent design, deployment technique, and operator experience. Patients with complex anatomical features, extensive disease involvement, or comorbidities may be at higher risk of experiencing stent-related complications, necessitating careful patient selection and personalized treatment strategies.
Opportunities:
- Expanding Geriatric Population
- Increasing Preference for Minimally Invasive Procedures
-
Growing Prevalence of Gastrointestinal Disorders - One of the primary opportunities driving the growth of the GI stents market is the growing prevalence of gastrointestinal disorders. Factors contributing to this increase include changing dietary habits, sedentary lifestyles, aging populations, and the rising incidence of risk factors such as obesity and smoking. As a result, there is a rising demand for minimally invasive treatment options to alleviate symptoms, improve quality of life, and prolong survival rates among patients with gastrointestinal conditions.
GI stents serve as crucial medical devices in the management of gastrointestinal disorders, offering a minimally invasive alternative to traditional surgical interventions. These stents are designed to relieve obstructions, maintain luminal patency, and facilitate the passage of fluids and solids through the affected areas of the gastrointestinal tract. They can be deployed endoscopically or radiologically, providing immediate symptom relief and restoring normal gastrointestinal function.
The growing prevalence of gastrointestinal disorders presents a substantial market opportunity for GI stent manufacturers and healthcare providers. As the burden of these conditions continues to rise, there is an increasing need for advanced stenting technologies that offer improved efficacy, safety, and patient outcomes. Manufacturers are investing in research and development efforts to innovate stent designs, materials, and delivery systems, aiming to address the specific anatomical and clinical challenges associated with different gastrointestinal disorders.
Advancements in endoscopic techniques, imaging modalities, and stent placement procedures have expanded the scope of gastrointestinal interventions, enabling the treatment of complex cases and high-risk patients. Healthcare providers are increasingly adopting a multidisciplinary approach to the management of gastrointestinal diseases, incorporating stent placement as a key component of comprehensive treatment strategies.
Competitive Landscape Analysis
Key players in Global Gastrointestinal (GI) Stents Market include:
- Olympus Corporation
- Boston Scientific Corporation
- Hobbs Medical Inc.
- Conmed Corporation
- Becton Dickinson and Company
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Gastrointestinal (GI) Stents Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Prevalence of Gastrointestinal Disorders
-
Advancements in Stent Technology
-
Aging Population and Increasing Endoscopic Procedures
-
- Restraints
-
Availability of Alternative Treatment Modalities
-
Stringent Regulatory Approval Processes
-
Complications Associated with Stenting Procedures
-
- Opportunities
-
Expanding Geriatric Population
-
Increasing Preference for Minimally Invasive Procedures
-
Growing Prevalence of Gastrointestinal Disorders
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Gastrointestinal (GI) Stents Market, By Product, 2021 - 2031 (USD Million)
-
Biliary Stent
-
Duodenal Stent
-
Colonic Stent
-
Pancreatic Stent
-
Esophageal Stent
-
- Global Gastrointestinal (GI) Stents Market, By Application, 2021 - 2031 (USD Million)
-
Biliary Disease
-
Colorectal Cancer
-
Stomach Cancer
-
Others
-
- Global Gastrointestinal (GI) Stents Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Gastrointestinal (GI) Stents Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Olympus Corporation
- Boston Scientific Corporation
- Hobbs Medical Inc.
- Conmed Corporation
- Becton Dickinson and Company
- Company Profiles
- Analyst Views
- Future Outlook of the Market